Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 141

1.

PAX 8 expression in non-neoplastic tissues, primary tumors, and metastatic tumors: a comprehensive immunohistochemical study.

Ozcan A, Shen SS, Hamilton C, Anjana K, Coffey D, Krishnan B, Truong LD.

Mod Pathol. 2011 Jun;24(6):751-64. doi: 10.1038/modpathol.2011.3. Epub 2011 Feb 11.

2.

PAX-2 expression in non-neoplastic, primary neoplastic, and metastatic neoplastic tissue: A comprehensive immunohistochemical study.

Zhai QJ, Ozcan A, Hamilton C, Shen SS, Coffey D, Krishnan B, Truong LD.

Appl Immunohistochem Mol Morphol. 2010 Jul;18(4):323-32. doi: 10.1097/PAI.0b013e3181d712ef.

PMID:
20216401
3.

Diagnostic utility of thyroid transcription factors Pax8 and TTF-2 (FoxE1) in thyroid epithelial neoplasms.

Nonaka D, Tang Y, Chiriboga L, Rivera M, Ghossein R.

Mod Pathol. 2008 Feb;21(2):192-200. Epub 2007 Dec 14.

4.

PAX2 and PAX8 expression in primary and metastatic müllerian epithelial tumors: a comprehensive comparison.

Ozcan A, Liles N, Coffey D, Shen SS, Truong LD.

Am J Surg Pathol. 2011 Dec;35(12):1837-47. doi: 10.1097/PAS.0b013e31822d787c.

PMID:
21989345
5.

A comprehensive analysis of PAX8 expression in human epithelial tumors.

Laury AR, Perets R, Piao H, Krane JF, Barletta JA, French C, Chirieac LR, Lis R, Loda M, Hornick JL, Drapkin R, Hirsch MS.

Am J Surg Pathol. 2011 Jun;35(6):816-26. doi: 10.1097/PAS.0b013e318216c112.

PMID:
21552115
6.

PAX2 and PAX8 expression in primary and metastatic renal tumors: a comprehensive comparison.

Ozcan A, de la Roza G, Ro JY, Shen SS, Truong LD.

Arch Pathol Lab Med. 2012 Dec;136(12):1541-51. doi: 10.5858/arpa.2012-0072-OA.

PMID:
23194047
7.

Evaluation of putative renal cell carcinoma markers PAX-2, PAX-8, and hKIM-1 in germ cell tumors: a tissue microarray study of 100 cases.

Sangoi AR, McKenney JK, Brooks JD, Bonventre JV, Higgins JP.

Appl Immunohistochem Mol Morphol. 2012 Oct;20(5):451-3. doi: 10.1097/PAI.0b013e31824bb404.

8.

Value of PAX 8 immunostaining in tumor diagnosis: a review and update.

Ordóñez NG.

Adv Anat Pathol. 2012 May;19(3):140-51. doi: 10.1097/PAP.0b013e318253465d. Review.

PMID:
22498579
9.

Specificity of brachyury in the distinction of chordoma from clear cell renal cell carcinoma and germ cell tumors: a study of 305 cases.

Sangoi AR, Karamchandani J, Lane B, Higgins JP, Rouse RV, Brooks JD, McKenney JK.

Mod Pathol. 2011 Mar;24(3):425-9. doi: 10.1038/modpathol.2010.196. Epub 2010 Nov 19.

10.

Napsin A and thyroid transcription factor-1 expression in carcinomas of the lung, breast, pancreas, colon, kidney, thyroid, and malignant mesothelioma.

Bishop JA, Sharma R, Illei PB.

Hum Pathol. 2010 Jan;41(1):20-5. doi: 10.1016/j.humpath.2009.06.014. Epub 2009 Sep 8.

PMID:
19740516
11.

PAX8 expression reliably distinguishes pancreatic well-differentiated neuroendocrine tumors from ileal and pulmonary well-differentiated neuroendocrine tumors and pancreatic acinar cell carcinoma.

Sangoi AR, Ohgami RS, Pai RK, Beck AH, McKenney JK, Pai RK.

Mod Pathol. 2011 Mar;24(3):412-24. doi: 10.1038/modpathol.2010.176. Epub 2010 Oct 1.

12.

Pax8: a marker for carcinoma of Müllerian origin in serous effusions.

Tong GX, Devaraj K, Hamele-Bena D, Yu WM, Turk A, Chen X, Wright JD, Greenebaum E.

Diagn Cytopathol. 2011 Aug;39(8):567-74. doi: 10.1002/dc.21426. Epub 2010 Jul 6.

PMID:
20607683
13.

Expression of Pax-8, p53 and bcl-2 in human benign and malignant thyroid diseases.

Puglisi F, Cesselli D, Damante G, Pellizzari L, Beltrami CA, Di Loreto C.

Anticancer Res. 2000 Jan-Feb;20(1A):311-6.

PMID:
10769673
14.

Immunohistochemical distinction of renal cell carcinoma from other carcinomas with clear-cell histomorphology: utility of CD10 and CA-125 in addition to PAX-2, PAX-8, RCCma, and adipophilin.

Mentrikoski MJ, Wendroth SM, Wick MR.

Appl Immunohistochem Mol Morphol. 2014 Oct;22(9):635-41. doi: 10.1097/PAI.0000000000000004.

PMID:
25279712
15.

Expression of PAX8 in normal and neoplastic renal tissues: an immunohistochemical study.

Tong GX, Yu WM, Beaubier NT, Weeden EM, Hamele-Bena D, Mansukhani MM, O'Toole KM.

Mod Pathol. 2009 Sep;22(9):1218-27. doi: 10.1038/modpathol.2009.88. Epub 2009 Jun 12.

16.

PAX8 Expression in well-differentiated pancreatic endocrine tumors: correlation with clinicopathologic features and comparison with gastrointestinal and pulmonary carcinoid tumors.

Long KB, Srivastava A, Hirsch MS, Hornick JL.

Am J Surg Pathol. 2010 May;34(5):723-9. doi: 10.1097/PAS.0b013e3181da0a20.

PMID:
20414099
17.

PAX-8 expression in primary and metastatic Merkel cell carcinoma: an immunohistochemical analysis.

Sangoi AR, Cassarino DS.

Am J Dermatopathol. 2013 Jun;35(4):448-51. doi: 10.1097/DAD.0b013e318271ce53.

PMID:
23612030
18.

The utility of PAX-2 and renal cell carcinoma marker immunohistochemistry in distinguishing papillary renal cell carcinoma from nonrenal cell neoplasms with papillary features.

Sharma SG, Gokden M, McKenney JK, Phan DC, Cox RM, Kelly T, Gokden N.

Appl Immunohistochem Mol Morphol. 2010 Dec;18(6):494-8. doi: 10.1097/PAI.0b013e3181e78ff8.

PMID:
21102195
19.

PAX8 and PAX2 immunostaining facilitates the diagnosis of primary epithelial neoplasms of the male genital tract.

Tong GX, Memeo L, Colarossi C, Hamele-Bena D, Magi-Galluzzi C, Zhou M, Lagana SM, Harik L, Oliver-Krasinski JM, Mansukhani M, Falcone L, Hibshoosh H, O'Toole K.

Am J Surg Pathol. 2011 Oct;35(10):1473-83. doi: 10.1097/PAS.0b013e318227e2ee.

PMID:
21934480
20.

Supplemental Content

Support Center